Increasing Prevalence Of Chronic Diseases Is Driving The Growth Of The Market: A Significant Driver Propelling The Infusion Therapy Devices Market In 2025

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Infusion Therapy Devices Market Size and Projected Growth Rate?
The market size for infusion therapy devices has expanded significantly over the past few years. The value is projected to jump from $12.10 billion in 2024 to $13.43 billion in 2025, marking a compound annual growth rate (CAGR) of 11.0%. This substantial growth during the historical period can be ascribed to a rise in hospital admissions, enhanced healthcare infrastructure, governmental initiatives, the increasing prevalence of medical tourism, and beneficial reimbursement policies.

In the coming years, the market for infusion therapy devices is projected to experience brisk expansion. The market is predicted to swell to $20.11 billion by 2029, driven by a CAGR of 10.6%. This growth during the forecast period is expected to be fueled by factors such as personalized medicine, preparedness and response to pandemics, wearable infusion equipment, a shift towards infusion therapy, and digitalization in healthcare. Key trends forecasted for this period include 5g connectivity, quantum computing, integration of the Internet of Things (IoT), wearable healthcare technology, and the adoption of voice assistants and natural language processing.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20849

What Are the Major Segments in the Infusion Therapy Devices Market?
The infusion therapy devices market covered in this report is segmented -

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors
2) By Mobility: Portable Infusion Pumps, Stationary Pumps
3) By Application: Oncology, Diabetes, Pain Management, Other Applications
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps
2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters
3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas
4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

What Are The Driving Infusion Therapy Devices Market Evolution?
The surge in chronic diseases is anticipated to drive the expansion of the infusion therapy devices market. Chronic diseases are long-term health issues that last a year or more, needing constant medical care or limiting everyday activities. The rise in these diseases may be attributed to unhealthy lifestyle choices, lack of physical activity, poor eating habits, and environmental factors, as well as an increase in risk aspects like obesity, smoking, and stress. Infusion therapy devices handle chronic ailments by accurately delivering medications and fluids directly into the bloodstream. This ensures effective and consistent treatment of conditions such as diabetes, autoimmune disorders, and cancer, thereby enhancing patient outcomes, providing greater convenience, and reducing frequent hospital visits. For example, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, forecasted in January 2023 that the count of individuals aged 50 and older with at least one chronic disease will leap by 99.5% by 2050, increasing from 71.522 million in 2020 to 142.66 million. Hence, the escalating occurrence of chronic diseases is propelling the growth of the infusion therapy devices market.

Which Firms Dominate The Infusion Therapy Devices Market Segments?
Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, Acelity L.P Inc., LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., AccuVein Inc.

What Trends Are Expected to Dominate the Acquired Autoimmune Hemolytic Anemia Market in the Next 5 Years?
Leading firms in the infusion therapy devices market are concentrating on the creation of cutting-edge solutions such as pressure-enabled drug delivery (PEDD) technology, aimed at improving the treatment of liver and pancreatic tumors. PEDD is a drug distribution method that uses pressure to boost the infusion of therapeutic agents into tissues or organs, especially in regions where traditional methods may run into obstacles. For example, in November 2024, TriSalus Life Sciences, a medical technology firm based in the United States, unveiled the TriNav LV Infusion System and TriGuide Guiding Catheters. This boosted its PEDD portfolio, aiming to increase therapeutic delivery, enrich treatment alternatives, and potentially advance results for patients. The TriNav LV Infusion System comes with distinctive features such as larger blood vessels (3.5 to 5.0 mm), widening the use of TriSalus' PEDD technology to a range of patients. This launch extends compatibility of PEDD devices from 1.5 mm to 5.0 mm vessels, providing more treatment possibilities for interventional radiologists. TriGuide Guiding Catheters come with a larger inner diameter, a slippery lining, and a reverse curve design for simpler femoral access and increased procedural productivity. Early adopters report a 97% approval rate, underlining the system's efficiency and user-friendliness in cancer treatments.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Which Is The Largest Region In The Infusion Therapy Devices Market?
North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Infusion Therapy Devices Market?
2. What is the CAGR expected in the Infusion Therapy Devices Market?
3. What Are the Key Innovations Transforming the Infusion Therapy Devices Industry?
4. Which Region Is Leading the Infusion Therapy Devices Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.